White Coat Investor Podcast cover image

WCI #326: Finances for Doctors With a Terminal Illness

White Coat Investor Podcast

00:00

The Benefits of EGFR on Lung Cancer

EGFR is an epsil growth factor receptor. There are a number of mutations and some people may have had it. I'm on a medication called TEGRIS that targets this mutation. And so over the years they've started to develop more of these tyrosine kinase inhibitors. They're having less side effects as well, which is good.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app